Use the Back button in your browser to see the other results of your search or to select another record.
| Efficacy and safety of Supine Daoyin in the treatment of acute exacerbation of chronic obstructive pulmonary disease: a randomized controlled trial |
| Li J, Zhang H, Wang J, Lu X, Zuo M, Jiao L, Lu X, Wang Y |
| Journal of Evidence-Based Medicine 2024 Sep;17(3):654-666 |
| clinical trial |
| 7/10 [Eligibility criteria: No; Random allocation: Yes; Concealed allocation: Yes; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
|
Copyright release for this abstract has not been granted.
|